Amarantus Bioscience Holdings Inc (AMBS)

[MUKA1]

CEO referred to "additional product lines in the diagnostic" area. He also mentioned that the dilution resulted in a "stronger company with more prospects."

Cerora, Inc is developing its MindReader™ platform to commercialize a non-invasive, accurate, accessible and affordable mobile device to aid in the diagnosis of TBI. This talk with provide an overview of the device along with the “cloud” based neuro diagnostics as a service IT infrastructure. Preliminary findings from a pilot cross sectional clinical study design will be presented.

This was the presented material by Adam Simon at the TBI conference last month. Simon is the Pres/CEO of Cerora. If he is coming on board AMBS, perhaps he is bringing this diagnostic tool as well.

Speculation only.